GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Earnings per Share (Diluted)

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Earnings per Share (Diluted) : ₹1.57 (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Earnings per Share (Diluted)?

Vaidyane Ayurved Laboratories's Earnings per Share (Diluted) for the six months ended in Mar. 2024 was ₹0.64. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.57.

Vaidyane Ayurved Laboratories's EPS (Basic) for the six months ended in Mar. 2024 was ₹0.76. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.88.

Vaidyane Ayurved Laboratories's EPS without NRI for the six months ended in Mar. 2024 was ₹0.40. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.33.

During the past 12 months, Vaidyane Ayurved Laboratories's average EPS without NRIGrowth Rate was -71.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -1.20% per year.

During the past 6 years, Vaidyane Ayurved Laboratories's highest 3-Year average EPS without NRI Growth Rate was 157.10% per year. The lowest was -1.20% per year. And the median was 77.95% per year.


Vaidyane Ayurved Laboratories Earnings per Share (Diluted) Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Earnings per Share (Diluted) Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Earnings per Share (Diluted)
Get a 7-Day Free Trial -0.53 0.37 8.00 4.60 1.57

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only 2.01 2.60 2.00 0.93 0.64

Competitive Comparison of Vaidyane Ayurved Laboratories's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaidyane Ayurved Laboratories's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's PE Ratio distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's PE Ratio falls into.



Vaidyane Ayurved Laboratories Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Vaidyane Ayurved Laboratories's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(19.803-0)/12.648
=1.57

Vaidyane Ayurved Laboratories's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(8.045-0)/12.653
=0.64

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹1.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Vaidyane Ayurved Laboratories  (NSE:MADHAVBAUG) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Vaidyane Ayurved Laboratories Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaidyane Ayurved Laboratories Business Description

Traded in Other Exchanges
N/A
Address
201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines